Objective. Chronic pain is experienced by one in five Australians and is estimated to be the nation's third most costly health problem. In 2013, a chronic pain treatment outcomes registry was established, with the goals of evaluating treatment of chronic pain in multidisciplinary centers, establishing a benchmarking system to drive quality improvement and providing answers to important questions regarding types of treatment ("dose," intensity, and response) and which treatment is appropriate for different patients. This paper describes the development and the first-phase implementation of the registry.
Introduction
Chronic pain imposes a significant personal and economic burden on the individual and society. Similar to many other countries, one in five Australians experience chronic pain [1, 2] , with this experience commonly associated with increased rates of depression, anxiety, relationship problems, and exclusion from the workforce [3, 4] . Pain is Australia's third most costly health problem, with a 2007 estimated annual expenditure of over $34.3 billion dollars [5] .
In an effort to address the impact of chronic pain in Australia, a collaboration of 150 organizations led by the Faculty of Pain Medicine of the Australian and New Zealand College of Anaesthetists (FPM), the Australian Pain Society (APS), consumer groups, and other stakeholders championed an integrated approach to the treatment of chronic and acute pain. The result was the National Pain Strategy 2010 (NPS) [6] , the aim of which was to "improve quality of life for people with pain and their families, and to minimize the burden of pain on individuals and the community" (pp. 4). The NPS outlined goals and priority objectives for the sector, among these the need to measure, evaluate, and report information relating to treatment outcomes and develop a quality improvement and national benchmarking process.
In 2011, the FPM hosted a workshop to progress the outcome evaluation and benchmarking agenda. There was representation from the APS, New Zealand Pain Society (NZPS), and FPM. The FPM's strategic plan was to work with the Australian Health Services Research Institute (AHSRI), University of Wollongong, as preferred provider based on their track record of providing national benchmarking for palliative care and rehabilitation medicine. On this basis, an AHSRI representative attended the workshop. The major outcomes of the workshop were agreement on a provisional minimum data set and a collective intention to seek suitable funding for the initiative.
The next critical step came in 2012 with the announcement that the New South Wales (NSW) Ministry of Health (a government department in Australia's most populous state) would fund enhancement of chronic pain services across the state, consistent with the goals of the National Pain Strategy. The NSW Agency for Clinical Innovation (ACI) would oversee implementation of the NSW Pain Plan and bring forward clinician voices via a Pain Network to develop an integrated model of care. Within the enhancement package, specific funding was allocated to establish a minimum data set for specialist pain management services. This initiative, named electronic Persistent Pain Outcomes Collaboration (ePPOC), would commence in NSW but with a vision to expand and ensure consistent and standardized data collection in services across Australia and New Zealand. The benefits of implementing the minimum data set would include the ability to make meaningful comparisons between services, develop a benchmarking system to improve pain management outcomes, identify best practice protocols and variations in service provision, and establish a research agenda to address areas of interest within the national and international pain management sector.
Implementation of ePPOC began in 2013. This paper describes the initiative, outlines the processes relating to its development and implementation, and briefly reports early data describing the characteristics of patients treated in the participating pain management services. A similar outcomes collaboration for the pediatric pain management sector (PaedePPOC) has also been established and will be described in a separate paper.
Methods
The initial phase of ePPOC's development involved gaining agreement on the domains and items to be included in the minimum data set, defining a protocol for collecting and reporting the data, establishing appropriate governance structures, and developing resources to support the participating pain services. The program was then progressively implemented throughout specialist pain management services. Each of these activities is described in the sections below.
Governance
AHSRI had significant previous experience in establishing and managing outcome collaborations in the related fields of rehabilitation medicine (Australasian Rehabilitation Outcomes Collaboration; AROC) and palliative care (Palliative Care Outcomes Collaboration; PCOC), and similar governance and workforce approaches were employed in the development of ePPOC. Additional AHSRI staff recruited to support ePPOC included a manager, statistician, software developer, and administration officer.
In order to ensure that ePPOC developed with a focus representative of the broad Australasian pain management sector, a National Reference Group (NRG) was formed to guide the establishment phase. Members of the NRG were governmental and clinical representatives from the Australian states and territories and New Zealand, tasked with guiding the activities of ePPOC during its first year of operation. The NRG supervised further development of the ePPOC minimum data set, the protocol for collection of data, and the resources and policies necessary to support the initiative.
Following a one-year establishment phase, the NRG was disbanded and two new groups established to support the ongoing implementation and development of ePPOC: a Management Advisory Group responsible for the executive management of ePPOC and a Scientific and Clinical Advisory Committee to determine research priorities and provide advice on matters relating to data and reporting. This committee is also responsible for assessing requests for ePPOC data for scientific merit and public health importance.
An ACI Database and Outcomes Working Group comprising clinicians from pain services throughout NSW provided feedback on the processes, data items, and software during the development and implementation phases.
Ethics
The establishment of ePPOC was approved by the University of Wollongong Health and Medical Human Research Ethics Committee. This approval allows collection of patient-deidentified outcome and servicerelated information from participating units without patient consent, for the purposes of reporting, quality assurance, and benchmarking. Individual pain services have sought advice from their local ethics committees as to whether approval was required to participate in ePPOC. Consequently, some services have moved to gain local ethics approval while others have not. No local committee declined or placed restrictions on any service's participation in ePPOC.
Ethical approval by the University of Wollongong is reviewed yearly, and all future proposals to use ePPOC data for research purposes will be subject to ethical review.
Establishment of the "Minimum Data Set"
Early work in 2011 led by members of the FPM together with the APS and NZPS resulted in consensus regarding the domains of interest and standardized assessment tools for a minimum data set. The international published work of the IMMPACT group regarding outcome measures for chronic pain research led by Dworkin and colleagues [7, 8] also provided direction regarding suitable questionnaires and outcome domains. The Victorian Department of Health expressed interest and funded an 18-month trial of the data set across three centers (Alfred Health, Melbourne Health, and Ballarat Health), called the Victorian Persistent Pain Outcome Project [9] . The proposed data set was further refined and defined during 2013 by the ePPOC NRG and ACI Database and Outcomes Working Group.
The choice of clinical assessment measures was driven by a number of factors. Of critical importance was their clinical utility. Clinical utility was paramount in order to ensure that the primary purpose of their collection is the routine assessment, triage, and monitoring of patients within the pain management unit. Research, reporting, and benchmarking are secondary uses of the information. As pain and its related issues can be difficult for clinicians to observe or independently assess, ePPOC also chose to adopt an approach focused on patientreported outcome measures.
All of the measures selected had to demonstrate validity, reliability, and sensitivity to change in the patient population. As chronic pain is a multidimensional condition, a broad range of assessment tools were needed to assess physical, functional, and psychological domains. Also taken into consideration were consistencies with information currently collected in the pain management services, acceptability and burden for patients and staff and availability of the measure in other languages. The cost associated with use was also an important consideration (and one that ruled out a number of existing assessment tools), as it would not have been possible to mandate the use of a tool that involved a financial cost for participating services. Information regarding tool selection is also presented in the Victorian Persistent Pain Outcome Project [9] .
In total, the data set contains 86 items. This includes 17 registration and demographic items, a total of 56 questions in five separate clinical assessment tools and supplementary questions about medication, health services utilization, and treatment provided. The time required to complete the questionnaires is estimated to be 15 minutes; however, this will vary between patients according to factors including age, language, and level of disability. The clinical measures included in the minimum data set are described briefly below. The domains assessed and the items within each are shown in Table 1 .
Brief Pain Inventory
The Brief Pain Inventory (BPI) is a measure assessing the location of pain, its severity, and its interference in daily activities [10] . ePPOC uses 11 questions from the BPI to measure pain severity (average, worst, least, and now) and interference (general activity, mood, walking ability, work, relations with others, sleep, and enjoyment) over the past week. Patients rate pain severity and intensity on a 0 to 10 rating scale. For the severity items, 0 represents "no pain" and 10 "pain as bad as you can imagine." For the interference items, 0 represents "does not interfere" and 10 "completely interferes." The BPI was chosen as it allows ePPOC to measure the severity and impact of pain using a numeric rating scale via a tool that is widely used, has good psychometric properties, and is available in many languages.
Body Map
The body map developed by the Childhood Arthritis and Rheumatology Research Alliance (CARRA) [11] is used to assess the location of the patient's main and additional pain. This replaced the BPI body chart soon after ePPOC implementation, as the delineated regions facilitated standard reporting of pain location.
Depression Anxiety Stress Scale
The Depression Anxiety Stress Scale (DASS) is a patient-reported measure of the emotional states of depression, anxiety, and stress [12] . ePPOC uses the short version of the DASS, the DASS21. The DASS21 asks patients to read a list of 21 statements and rate how much each applied over the past week. Statements are scored on a scale where 0 ¼ "did not apply to me at all," 1 ¼ "applied to me to some degree, or some of the time," 2 ¼ "applied to me to a considerable degree, or a good part of the time," and 3 ¼ "applied to me very much, or most of the time."
This tool was selected as it assesses three areas of interest in the management of chronic pain (depression, anxiety, and stress), is widely used within Australia and New Zealand, and has been shown to be valid, reliable, and appropriate for use in patients experiencing persistent pain [13, 14] . Furthermore, the DASS depression subscale does not emphasize somatic symptoms, such as fatigue and sleep difficulties. These symptoms are often experienced by patients with chronic pain, and there has been concern that responses to these items Electronic Persistent Pain Outcomes Collaboration are influenced by pain rather than depression, leading to an overestimation of depression severity in this population [13, 15] .
Pain Self-Efficacy Questionnaire
Pain self-efficacy refers to the confidence a person has that he or she can perform a range of activities, despite the presence of pain. It was included as an important domain to measure due to the increasing body of research linking pain self-efficacy to pain behaviors and treatment outcomes. The 10-item Pain Self-Efficacy Questionnaire (PSEQ) [16] was chosen as the tool to assess pain self-efficacy in the ePPOC data set. The PSEQ asks patients to rate how confident they are that they can do a range of activities despite their pain. Ratings are on a scale of 0 to 6, where 0 ¼ "not at all confident" and 6 ¼ "completely confident." This tool is widely used throughout Australia and internationally, is being validated in an increasing number of languages, and has strong psychometric properties [17] . Studies using the PSEQ have demonstrated a relationship between pain self-efficacy and many factors important in the management of pain, including pain-related disabilities and pain intensity [17, 18] , return to work [19] , and pain-related fear and quality of life [20] .
Pain Catastrophising Scale
The Pain Catastrophising Scale (PCS) was included in the ePPOC minimum data set to allow measurement of pain-related thoughts and cognitions that may contribute to more intense pain, increased disability, and emotional distress [21] . This tool is widely used, quick to complete, and has been shown to predict pain severity and pain-related disability [22] . The PCS consists of 13 statements describing different thoughts, and patients are asked to rate the degree to which they experience these on a 0 to 4 scale. A score of 0 represents "not at all," 1 ¼ "to a slight degree," 2 ¼ "to a moderate degree," 3 ¼ "to a great degree," and 4 ¼ "all the time." The PCS provides an overall catastrophizing score, as well as subscale scores measuring rumination, magnification, and helplessness.
Medication Use
One of the important outcomes to be measured under ePPOC is medication use. At each assessment point, patients are asked to provide a list of all medications taken, the strength, number per day, and how many days per week they take each medication. Pain management staff transform this information into three variables: the oral daily morphine equivalent, the number of major pain-related drug groups the medications fall into, and whether the patient is taking opioid medication on more than two days per week. In order to ensure standardization of the opioid calculations, a working group of the FPM developed an Opioid Dose Equivalence Guideline to be used in pain management services in Australia and New Zealand [23] . This includes a tool to calculate oral morphine equivalent daily dose. Other medications are allocated to a list of the five other major pain-related drug groups: paracetamol, NSAIDs, anticonvulsants, antidepressants, and benzodiazepines. The clinical consensus was that opioid use on more than two days per week constituted regular as opposed to intermittent use. This variable is use to report the proportion of patients on regular opioid therapy at significant time points (e.g., referral and discharge).
Health Care Utilization
A method of recording health care utilization was adapted from Hunter Integrated Pain Service [16] , which inquired about pain-related frequency of visits to general practitioners, specialists, other practitioners, and emergency departments, along with number of inpatient admissions and diagnostic tests. Health managers, funding bodies, and politicians would like to see a reduction in health care utilization and hence direct costs following multidisciplinary pain service intervention. As a person experiencing chronic pain learns more about his or her condition and adopts an active self-management approach, it is to be anticipated that health care (in both primary and hospital systems) will reduce. We hope that by collecting information in this domain we will be able to demonstrate another zone of tangible benefit from multidisciplinary pain management.
Protocol
The protocol for collection of the patient-rated data was developed following extensive consultation with pain management services, the ACI Database and Outcomes Working Group, and the NRG. The patient-rated questionnaires are collected at the following time points:
• On receipt of referral to the pain management service-to obtain a baseline measure.
• At the start of treatment-questionnaires are collected at this point if the referral questionnaire was completed more than six months ago. Collection is optional if the period between treatment start and referral questionnaire completion is three to six months and not required if this period is less than three months.
• At the end of treatment (defined as the end of the episode at the pain management service)-to assess the effectiveness of the intervention.
• Three to six months after treatment has ended-to assess whether changes were maintained.
• Within the treatment period-pain management services are also encouraged to review patient progress if active treatment exceeds six months.
This protocol has a number of advantages for reporting outcomes. Firstly, the collection occasions coincide with clinically meaningful events in the patient's episode of care (e.g., referral, start of treatment) rather than being at fixed time intervals (e.g., six monthly), which may occur, for example, in the middle of a group pain management program or before a patient has started treatment. Secondly, as waiting times for specialist pain services can be lengthy, this collection protocol allows assessment of change in a patient's status from the time of referral to the start of treatment. Evidence indicates that this waiting period often leads to significant reduction in quality of life [24] . Finally, the collection of outcome measures throughout the period of ongoing relationship between the patient and the pain management service should help to maximize the outcome data collected.
From a pragmatic point of view, this protocol can amount to quite frequent reassessment, and ongoing evaluation of the success of the data collection schedule and follow-up will inform future refinements.
Resources Developed for Participating Services

Software Development
One of the challenges for ePPOC is collecting data conveniently from outpatient clinics, as distinct from other registries evaluating change over inpatient care, where there are defined episode end points and patient and staff compliance are higher. In addition, the focus on collecting patient-rated outcome measures on a routine basis means finding an efficient and convenient way for patients to provide this information. In response to these challenges, ePPOC developed purpose-built software, epiCentre, for the collection and management of the data.
epiCentre consists of a desktop application for the entry of patient data, with an integrated electronic data capture tool (Research Electronic Data Capture; REDCap) [25] , hosted at the University of Wollongong. REDCap is a secure, web-based application designed to support data capture for research studies, providing 1) an intuitive interface for validated data entry, 2) audit trails for tracking data manipulation and export procedures, 3) automated export procedures for seamless data downloads to common statistical packages, and 4) procedures for importing data from external sources. Its use within ePPOC allows patients the option of completing the questionnaires online and offsite.
Other important considerations in developing epiCentre were clinical utility, allowing real-time use of the data by the pain management service, ease of data extraction, privacy and security of the data, and the ability for ePPOC to modify the software in response to user feedback.
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Reports
Comprehensive reports are provided to participating services every six months. These reports analyze an individual service's data for the period and compare the results to aggregated data from all other participating services. Demographic and service-related data are provided, along with information regarding patient clinical profiles and outcomes. The reports allow comparison of demographic indicators, clinical profiles, completion rates for data set items and assessment tools, and intensity and type of service provision. While outcome data are currently limited, the reports also provide detailed analyses of change in patient status for all assessment tools and outcome variables. Figures 1 and 2 show examples of the information provided in these reports for a fictitious pain service.
The schedule of six-monthly reporting was chosen to ensure that pain management services had sufficient time and capacity to respond to their results in a meaningful way, allowing, for example, comparison of their data from one period with another to assess change in outcomes in response to changes in the model of care. This frequency of reporting also ensures there is sufficient data within each reporting period.
Training and Support
Each participating service receives training and education regarding the ePPOC protocol, data items, and use of the software via site visits, webinars, and telephone and email support.
Clinical Significance Recommendations
To maximize the clinical utility of the data, ePPOC provides pain management services with recommendations regarding interpretation of change on each of the patient-rated assessment tools. Where possible, these recommendations have been taken from published guidelines. For example, IMMPACT states that a onepoint change on the BPI Inference Scale reflects minimally important change [26] . The same guidelines suggest that a decrease of 10-20%, more than 30%, or more than 50% on a 0-10 pain intensity numeric rating scale indicates minimal, moderate, and substantial clinical change, respectively. Where published guidelines did not exist, advice from the test developers or expert clinicians was sought. For example, the developer of the PSEQ advised that a change in score of seven or more points combined with movement to a different severity category indicates clinically significant change.
These recommendations have been built into a calculator for pain management services to use at the patient level to help determine whether an individual has made clinically significant change on the assessment tools.
Reference to the guidelines is also included in the ePPOC reports, which report the percentage of patients who experienced clinically significant change on each of the tools. For example, Figure 2 shows the distribution of change scores on the BPI Interference Scale for a fictitious pain service versus data for all other services participating in ePPOC. The accompanying text provides details of the proportion of patients who made clinically significant change.
Further details regarding these clinical significance recommendations and their utility within ePPOC will be the subject of a separate paper. Figure 2 Change on the BPI interference scale from referral to treatment end. The IMMPACT recommendation for assessment of clinically significant change on the BPI interference scale is a change of 1 or more points over the average of the 7 items. Forty-seven point four percent of your patients made clinically significant improvement, compared to 53.8% for all services. Scores for 5.3% of your patients increased (i.e., deteriorated) by 1 or more points (all services ¼ 7.6%), and 47.4% did not change (all services ¼ 38.7%).
Data Security, Quality, and Confidentiality
Each participating pain management service owns and has access to its own data. Every three months, staff at each service send a patient-deidentified extract of the data to ePPOC via a secure upload facility. While ePPOC data are patient-deidentified, there is a statistical linkage key (SLK) [27] that is automatically computed by epiCentre. The SLK allows identification of multiple episodes for a patient at one or more pain management services, giving a more accurate picture of patient numbers and patterns of utilization. It also allows linkage of the ePPOC data to other data sets.
Following each data submission, pain management units are sent a brief report summarizing the data that have been provided. This is checked by ePPOC and pain management staff to identify any omissions or systematic data errors. epiCentre also includes built-in checks at the point of data entry to minimize errors and missing data.
Confidentiality of participating units' data is essential, so no facility-level information is shown in public reports of ePPOC data. This anonymity is critical to the success of the collaboration: If there are concerns about reward or punishment for outcomes, the integrity of the data may be compromised and the process of setting and achieving benchmarks becomes meaningless.
Participation
Outpatient pain management units employing a multidisciplinary approach to treatment are eligible to participate in ePPOC, with an expectation that all patients of the service are included in the ePPOC data set. During the early implementation phase of ePPOC, pain management services within the state of NSW were asked to express interest and eight adult pain services were chosen to participate, representing metropolitan and rural, as well as newly and well-established services. After trialing the processes and software, the offer of ePPOC participation was extended to other pain management services throughout Australia and New Zealand.
Results
Implementation of ePPOC began in July 2013, with eight NSW public hospital adult pain services participating. The number of services has grown steadily-at the time of writing, 46 specialist centers in four Australian states and New Zealand had implemented, or were in the process of implementing, ePPOC.
Over the 24 months, there have been minor modifications to the data set, arising from direct experience with service users. Regular contact with participating pain units ensured that ePPOC was quickly aware of issues and able to address them. For example, the initial ePPOC data set used the BPI body chart to identify the location of the patients' pain. Services advised that the location of the pain was difficult to standardize and caused problems for patients when completing the questionnaire online. In response to this feedback, ePPOC modified the data set to substitute the CARRA body chart [11] , which includes delineated regions, facilitating standard reporting.
Ongoing feedback also led to substantial revisions of epiCentre to improve useability and enhance day-to-day clinical use of the data collected.
While epiCentre has been well received by staff at pain management units, deploying a standardized program to collect and use the ePPOC data also caused unforeseen problems. For example, while epiCentre is a small program and easily installed, navigation through hospital information technology services and their safeguards, as well as time restraints on hospital IT staff, meant that participation in ePPOC by a number of pain units was delayed by up to 12 months. The feature within epiCentre allowing online completion of questionnaires by patients was designed to reduce data entry time for staff; however, it has also required a shift of thinking for staff and patients away from paper-based questionnaires. This is particularly relevant to older patients and for large health services, where there may be duplication of data collected and IT systems that are not nimble. For services not previously engaged in data entry and analysis, use of epiCentre has resulted in additional burden for staff. As a stand-alone system, there may also be double-entry of demographic information and data related to service delivery (e.g., appointment date, type, and duration) into both epiCentre and the hospital medical record system. Some services are now investigating mechanisms to import data from the hospital electronic record to epiCentre to address this issue.
Among clinicians, support for ePPOC has generally been high. The clinicians are research-focused, enthusiastic about being part of a larger collaboration, and committed to achieving the best outcomes for their patients. Prior to the implementation of ePPOC, clinicians were already administering a variety of assessment tools to monitor patients and guide clinical decision-making. As a result, there has been little difficulty achieving buyin and support for a standardized program to achieve these same goals. In practice, however, clinicians have been challenged by the additional time required to participate in ePPOC. While much of the data collection and entry can be done by administrative staff, in most services clinicians play a role in monitoring or directing this process. This amounts to nonclinical time in pain centers that are largely funded for clinical activity. The additional time required to collect and enter data is likely to remain a challenge for many pain services.
Despite these challenges, 21 pain management services submitted data by December 31, 2014. At that time, these services had been participating for an average of nine months (range 1-16 months). In total, 6,361 patients were registered (average per unit 303 patients, range 17-703). The demographic characteristics and comorbidity profile of these patients are shown in Table 2 .
The patients completed a total of 6,267 questionnaires. The percent of validly completed assessment tools was high, exceeding 90% for all measures and subscales (see Table 3 ), suggesting patient acceptability of the tools. An initial questionnaire was completed by 5,015 patients (81.5%), with 12.3% of these patients also completing follow-up questionnaires at other time points. Seventeen point three percent of patients had not completed a questionnaire at the time the data were submitted to ePPOC.
The large number of referral questionnaires provide a rich source of data describing the population of patients attending pain management services in Australia. For example, the data show that, at referral, 61.0% of patients were using opioid medication on more than two days per week and using, on average, 2.9 of the six major pain-related drug groups identified (opioids, paracetamol, NSAIDs, anticonvulsants, antidepressants, and benzodiazepines). The average daily morphine equivalent for those patients using opioid medication was 86.9 mg (SD 106.7).
Over a third of patients (35.6%) were unemployed due to their pain, 77.4% responded that their pain affected the number of hours they were able to work or study, and 80.4% reported that pain affected the type of work they could do. Eighty-nine percent stated that their pain was always present.
The most common site of a patient's main pain was the back (43.0%), followed by arm and/or shoulder (9.6%), neck (7.5%), leg (7.3%), and head (6.6%). Nearly onehalf of patients (48%) had experienced pain for more than five years. The most common comorbid conditions were depression and/or anxiety (34.1%), other medical problems (26.0%), osteoarthritis and/or degenerative arthritis (23.6%), high blood pressure (20.7%), and diabetes (9.6%). Conditions listed under "other medical problems" are very diverse, including, for example, asthma, hernia, and high cholesterol. This category will be monitored periodically to ensure that medical conditions considered important in the management of pain are categorized separately and therefore more easily identified and reported.
Scores at referral on each of the assessment tools are shown in Table 4 . Approximately 20% of the questionnaires were collected at other points within a patient episode: 6.5% at the start of treatment, 3.3% at the end of the treatment, 7.6% during treatment, and 1.0% three months following discharge from the service. The small number of follow-up questionnaires is not surprising, given the recent implementation of ePPOC, combined with the relatively long wait times for patients to access specialist pain management services in Australia [28] and the length of episodes of care. Detailed analyses of patient outcomes will be reported once the proportion of follow-up data increases. Data collected by the pain management units also permits analysis and reporting of measures related to provision of treatment. For example, Figure 1 shows the number of days from receiving a patient's referral to the first clinical contact for each participating unit. While the average "wait time" is 104 days, there is considerable variability between services, ranging from 22 to 412 days. Lengthy waiting times for patients seen in publically funded pain services in Australia have been reported previously [28] , prompting many services to consider adopting new models of care-for example, replacing individual multidisciplinary assessment at the start of the episode with more time-efficient group education or assessment [29, 30] . Regular reporting of waiting times and other service-related measures by ePPOC will encourage this process of self-assessment and evaluation to continue.
Discussion
A persistent pain outcomes collaboration, in essence a chronic pain treatment outcome registry, has been established in Australasia and implemented in a sizable number of specialist pain management services in a relatively short period of time. This paper has described the process of establishment and implementation and briefly presented preliminary data. Nearly 50 services throughout Australia and New Zealand have now implemented, or are in the process of implementing, ePPOC.
This engagement with ePPOC and the volume and quality of data collected to date suggests the feasibility of the collaboration within the Australasian pain management sector.
The rapid establishment of the collaboration has been possible due to a number of factors. The collaborative work performed in 2011 by many organizations to develop a draft minimum data set meant that the framework for an outcomes collaboration was in place. The funding commitment from the NSW Ministry of Health then allowed employment of key staff to implement and further develop this framework. The leadership of key peak organizations such as the FPM and APS has been critical in driving clinician buy-in to ePPOC. This has proved to be an important factor and will remain fundamental to ePPOC's future success.
Other factors that aided the establishment and implementation process included: 1) AHSRI's previous experience in developing and managing similar outcome collaborations; 2) ensuring the ePPOC data set must firstly be useful for clinical purposes and secondly for research and benchmarking, thus maintaining clinical focus and clinician and consumer engagement; 3) the creation of free, supported software that could be modified to meet the needs of the users; and 4) development of clinically useful resources to support participating services, including the opioid dose equivalence guideline and clinical change calculator.
At the time of writing, the majority of data collected by participating pain management services has been at referral and commencement of treatment. While referral and treatment start data provide a valuable picture of the demographic and clinical characteristics of patients treated in specialist pain services, the current focus of the collaboration is to increase the number of measures collected at other time points. This is vital for assessing treatment outcomes and developing and evaluating benchmarks.
Collection of longer-term outcome data is understandably presenting more of a challenge for participating pain services for a number of reasons. For example, while the referral and treatment start information is easy to structure into clinical practice in an ambulatory service, additional clinical processes are required to capture patients at the end of treatment and to follow them up. Patient attrition is a significant challenge, with even established centers losing a percentage of patients to follow-up when they self-discharge or their contact details change [9] . Limited pain center resources also mean that there may be little time to pursue missing questionnaires. This may mean investigating use of briefer follow-up questionnaires and new technologies, including smart phone applications.
Long-standing policies and processes at many pain services have also hampered collection of patient outcome data. The ePPOC protocol requires that patient questionnaires are collected at the end of the episode, which was initially defined as discharge from the pain service. It became apparent in the early implementation phase, however, that many services do not discharge their patients, instead continuing to review them periodically for many years. For these patients, an end-of-episode and postepisode follow-up questionnaire may never be collected. While discharging patients is encouraged in our pain services, the definition of when to collect "end of episode" questionnaires has been refined to accommodate long-standing practices. This definition now states that the end of the episode occurs when active treatment ends, that is, when a group pain program ends and there is no intention to continue active treatment, or when the treating clinician begins to taper appointments.
While we believe that the majority of patients treated in the participating pain management services are registered in the ePPOC database, the figures reported here indicate that just over four in five completed an initial questionnaire. There are numerous potential explanations for this: These patients had not yet returned the questionnaire at the time the data were extracted; they were patients who were referred and registered but did not engage further with the pain management service; or they were unable to complete the questionnaire. Further work is required to address the latter explanation to ensure that ePPOC data accurately reflects the population of patients treated in pain management services.
The issue of patient noncompletion of questionnaires is also critical in the assessment of patient outcomes. With our outcome measures being highly dependent on patient self-report, assessment of treatment effectiveness is only available for those patients who are able to complete the questionnaires. Non-English-speaking patients and those with low levels of literacy or cognitive impairment will currently be underrepresented in outcome assessments. It has also become apparent that it is easier to collect follow-up data from patients receiving particular types of treatment, leading to the possibility of unequal representation of particular patients and their outcomes. For example, more follow-up data has been collected for patients in group pain programs, likely due to programs having a defined "end," which is less obvious in treatment involving appointments with (potentially) a number of different clinicians. Utilizing versions of the tools that have been validated in other languages and working with pain management services to identify and collect follow-up data regardless of the treatment pathway may help to ensure broad representation in the data set.
Securing ongoing funding will be essential for the longterm viability of ePPOC. The start-up funding was largely borne by one jurisdiction; however, the goal is that future costs can be shared by all participating services or funders (both government and private). Ultimately, this may require economic modeling of costs saved through patients improved by appropriate service delivery.
ePPOC is a work in progress, and there are clearly ongoing issues to address. However, in its short existence the collaboration has already delivered benefits to the Australasian pain sector. A standardized data set and protocol has allowed meaningful comparison between services. There is also greater interunit communication and a common language to describe treatment pathways and episodes. The analyses of data collected to date has provided a more detailed picture of the characteristics of patients referred to pain management services and has fostered enthusiasm for collection of follow-up measures to assess outcomes.
In the future, analysis of patient characteristics and outcome data will help pain management services to provide the most effective and efficient treatment to individual patients, in terms of treatment type (e.g., group vs individual) intensity, and balance of psychological, physical, and medical intervention. Data collected under ePPOC will allow assessment of the broader social and economic impact of pain management through analysis of employment status, health care utilization, and opioid use in patients experiencing persistent pain. We will be able to compare patient characteristics, treatment type, and outcomes across participating services and identify clinical variation between them. An important future goal for the collaboration is to set benchmarks for quality improvementallowing pain management services to view their performance relative to each benchmark and their peers and to learn from other services that are achieving the best results. The information collected under ePPOC will also form a large data set available for research into areas of interest within the pain management sector.
